“Increase in Multidrug-Resistant Organisms in Postoperative Peritonitis Patients from 1999-2019 Affects Empirical Antibiotic Therapy Adequacy”

https://pubmed.ncbi.nlm.nih.gov/38115142

The study found that the proportion of multidrug-resistant organisms (MDROs) in patients with postoperative peritonitis increased from 1999 to 2019, leading to a decrease in the adequacy of empirical antibiotic therapy, particularly for those receiving piperacillin/tazobactam or imipenem/cilastatin combined with vancomycin.